Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evotec SE - American Depositary Shares (NQ:EVO)

2.190 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 643
Open 2.190
Bid (Size) 2.020 (28,500)
Ask (Size) 2.060 (300)
Prev. Close 2.190
Today's Range 2.190 - 2.190
52wk Range 1.895 - 4.270
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Evotec Q2 Earnings Call Highlights ↗
Evotec (NASDAQ:EVO) reported preliminary unaudited results for the second quarter and first half of 2026 and lowered its full-year outlook, citing delayed strategic partnership revenue, slower... 
Via MarketBeat
Topics Earnings
News headline image
Evotec Appoints Rui Wang as Head of Global In Silico and AI
Via ACCESS Newswire

Performance

YTD
-31.1%
-31.1%
1 Month
-9.9%
-9.9%
3 Month
-19.3%
-19.3%
6 Month
-37.1%
-37.1%
1 Year
-42.5%
-42.5%

More News

Read More
News headline image
Evotec SE Successfully Placed €116.1 Million Convertible Bonds
Via ACCESS Newswire
News headline image
Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall
Via ACCESS Newswire
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
Evotec Receives Grants to Advance Tuberculosis Treatment
Via ACCESS Newswire
News headline image
Evotec Announces New Nomination to Board of Directors
Via ACCESS Newswire
News headline image
Evotec SE to Announce First Quarter 2026 Results on May 6, 2026
Via ACCESS Newswire
News headline image
Evotec Announces Chief Financial Officer Transition
Via ACCESS Newswire
News headline image
Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer
Via ACCESS Newswire
News headline image
Evotec (EVO) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Evotec Nominates Dieter Weinand as Supervisory Board Chairman
Via ACCESS Newswire
News headline image
Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026
Via ACCESS Newswire
News headline image
Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer
Via ACCESS Newswire
News headline image
Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses
Via ACCESS Newswire
News headline image
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
Via ACCESS Newswire
News headline image
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
Via ACCESS Newswire
News headline image
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
Via ACCESS Newswire
News headline image
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
Via ACCESS Newswire
News headline image
Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome
Via ACCESS Newswire
News headline image
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
Via ACCESS Newswire
News headline image
Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities
Via ACCESS Newswire
News headline image
In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties
Via ACCESS Newswire
News headline image
Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025
Via ACCESS Newswire
News headline image
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
Via ACCESS Newswire

Frequently Asked Questions

Is Evotec SE - American Depositary Shares publicly traded?
Yes, Evotec SE - American Depositary Shares is publicly traded.
What exchange does Evotec SE - American Depositary Shares trade on?
Evotec SE - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Evotec SE - American Depositary Shares?
The ticker symbol for Evotec SE - American Depositary Shares is EVO on the Nasdaq Stock Market
What is the current price of Evotec SE - American Depositary Shares?
The current price of Evotec SE - American Depositary Shares is 2.190
When was Evotec SE - American Depositary Shares last traded?
The last trade of Evotec SE - American Depositary Shares was at 08/12/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.